JP2013505290A5 - - Google Patents

Download PDF

Info

Publication number
JP2013505290A5
JP2013505290A5 JP2012530363A JP2012530363A JP2013505290A5 JP 2013505290 A5 JP2013505290 A5 JP 2013505290A5 JP 2012530363 A JP2012530363 A JP 2012530363A JP 2012530363 A JP2012530363 A JP 2012530363A JP 2013505290 A5 JP2013505290 A5 JP 2013505290A5
Authority
JP
Japan
Prior art keywords
methyl
dihydropyrrolo
pyrazol
oxy
piperidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2012530363A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013505290A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2010/053347 external-priority patent/WO2011036576A1/en
Publication of JP2013505290A publication Critical patent/JP2013505290A/ja
Publication of JP2013505290A5 publication Critical patent/JP2013505290A5/ja
Withdrawn legal-status Critical Current

Links

JP2012530363A 2009-09-23 2010-07-22 Gpr119調節因子 Withdrawn JP2013505290A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24506909P 2009-09-23 2009-09-23
US61/245,069 2009-09-23
PCT/IB2010/053347 WO2011036576A1 (en) 2009-09-23 2010-07-22 Gpr 119 modulators

Publications (2)

Publication Number Publication Date
JP2013505290A JP2013505290A (ja) 2013-02-14
JP2013505290A5 true JP2013505290A5 (cg-RX-API-DMAC7.html) 2013-07-25

Family

ID=42799871

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012530363A Withdrawn JP2013505290A (ja) 2009-09-23 2010-07-22 Gpr119調節因子

Country Status (5)

Country Link
US (1) US20130072427A1 (cg-RX-API-DMAC7.html)
EP (1) EP2480551A1 (cg-RX-API-DMAC7.html)
JP (1) JP2013505290A (cg-RX-API-DMAC7.html)
CA (1) CA2772188A1 (cg-RX-API-DMAC7.html)
WO (1) WO2011036576A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101913619B1 (ko) 2011-06-09 2018-12-28 리젠 파마슈티컬스 소시에떼 아노님 Gpr-119의 조절제로서의 신규한 화합물
US9328138B2 (en) 2011-11-15 2016-05-03 Msd Italia S.R.L. HCV NS3 protease inhibitors
AU2013290100A1 (en) 2012-07-11 2015-01-29 Elcelyx Therapeutics, Inc. Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
EP3181564B1 (en) 2012-11-20 2019-09-18 H. Hoffnabb-La Roche Ag Aminopyrimidine compounds as inhibitors of t790m containing egfr mutants
PT3728207T (pt) 2017-12-21 2023-03-14 Ribon Therapeutics Inc Quinazolinonas como inibidores de parp14

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3839694A1 (de) 1988-11-24 1990-05-31 Ats Leichtmetallraeder Gmbh Faltschachtel zur verpackung eines stossempfindlichen produkts, insbesondere einer leichtmetallfelge
ES1011809Y (es) 1989-10-23 1991-08-01 Minano Iglesias Jesus Muneco-envase.
CA2439152C (en) 2001-02-28 2008-06-17 Merck & Co., Inc. Acylated piperidine derivatives as melanocortin-4 receptor agonists
US7135575B2 (en) * 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
GEP20094723B (en) 2004-05-25 2009-07-10 Pfizer Prod Inc Tetraazabenzo [e] azulene derivatives and analogs thereof
PA8660701A1 (es) 2005-02-04 2006-09-22 Pfizer Prod Inc Agonistas de pyy y sus usos
JP5111398B2 (ja) * 2006-01-25 2013-01-09 メルク・シャープ・エンド・ドーム・コーポレイション 糖尿病の治療又は予防のためのジペプチジルペプチダーゼiv阻害剤としてのアミノシクロヘキサン類
TW200806669A (en) * 2006-03-28 2008-02-01 Merck & Co Inc Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
EP2152707B1 (en) * 2007-05-04 2012-06-20 Bristol-Myers Squibb Company [6,5]-bicyclic gpr119 g protein-coupled receptor agonists
AU2008279447A1 (en) 2007-07-19 2009-01-29 Metabolex, Inc. N-azacyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of the RUP3 or GPR119 receptor for the treatment of diabetes and metabolic disorders
JP5009736B2 (ja) 2007-10-15 2012-08-22 日本曹達株式会社 環状アミノエーテルを用いたマンニッヒ反応
WO2011061679A1 (en) * 2009-11-23 2011-05-26 Pfizer Inc. Imidazo-pyrazoles as gpr119 inhibitors

Similar Documents

Publication Publication Date Title
JP2012526096A5 (cg-RX-API-DMAC7.html)
JP7664156B2 (ja) Glp-1rアゴニスト及びその使用
JP2012528847A5 (cg-RX-API-DMAC7.html)
US8895583B2 (en) Soluble guanylate cyclase activators
KR102939810B1 (ko) 과혈당증의 치료에 사용하기 위한 헤테로아릴 치환된 베타-히드록시에틸아민
US9926314B2 (en) Compounds and compositions for the treatment of parasitic diseases
JP2017527604A (ja) sGC刺激剤
EA032028B1 (ru) СТИМУЛЯТОРЫ рГЦ
AU2004289638B2 (en) Substituted naphthyridinone derivatives
TWI749042B (zh) 作為飢餓素o-醯基轉移酶(goat)抑制劑的㗁二唑吡啶衍生物
US10596175B2 (en) Compounds and compositions for the treatment of parasitic diseases
TW201111381A (en) Pharmaceutical combinations useful for treating HCV
CN102639500A (zh) 三环化合物、其制备方法及其在医药上的应用
CN119255988A (zh) 杂环glp-1激动剂
JP2017527605A (ja) sGC刺激剤
US20140275013A1 (en) Compounds and compositions for the treatment of parasitic diseases
US20170298055A1 (en) sGC STIMULATORS
JP2024505711A (ja) 窒素含有多環式縮合環系化合物、その医薬組成物、製造方法及び用途
CN103619354A (zh) 止痒剂
EP3615545B1 (en) Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication
US20230149393A1 (en) Inhibitors of trpc6 for treating respiratory conditions
WO2011036576A1 (en) Gpr 119 modulators
WO2015066252A1 (en) Glucagon receptor antagonist compounds, compositions thereof, and methods of use
TWI570116B (zh) 取代的吡唑酮化合物及其使用方法
CN118141816A (zh) Sur2受体调节剂的用途